Literature DB >> 26308304

Kidneys from Older Living Donors Provide Excellent Short and Intermediate Outcomes--A Single China Center's Experience.

Turun Song1, Lei Fu, Zhengsheng Rao, Dongyang Zeng, Zhongli Huang, Xianding Wang, Mianzhi Chen, Qiang Wei, Tao Lin.   

Abstract

BACKGROUND: Transplantation with kidneys from older living donors is on the rise, yet controversy still exists over whether the outcomes are as satisfactory as with kidneys from younger donors.
METHODS: We retrospectively analyzed 1009 living donor kidney transplants performed at our center between 2006 and 2013. Graft and patient outcomes were compared between transplants with kidneys from old living donors (OLD, 55-65 years) (n = 264) and from young living donors (YLD, <55 years) (n = 745).
RESULTS: The age was 32.80 ± 9.71 years and 33.91 ± 5.98 years for recipient in YLD and OLD group, respectively. Death-censored graft survival at 1, 3, and 5 years was 98.8%, 97.1%, and 95.8% in patients receiving YLD kidneys, similar to the corresponding values of 97.6%, 95.5% and 95.5% in patients receiving OLD kidneys (P = 0.356). Patient survival at 1, 3, and 5 years after transplantation was also similar for patients receiving YLD kidneys (98.5%, 97.1%, and 96.7%) and for patients receiving OLD kidneys (99.6%, 99.6%, and 96.8%; P = 0.110). The OLD kidneys were not associated with increased risk of death-censored graft failure (hazard ratio, 2.5; 95% confidence interval, 0.57 to 11.11) and patient death (hazard ratio, 1.67; 95% confidence interval, 0.75 to 3.73). In addition, there is no increased graft loss or patient death for each 10-year increase in donor age. Transplantation with OLD kidneys was not associated with reduced patient or graft outcomes in the short term (≤ 12 months) or medium term (>1 year).
CONCLUSIONS: Graft and patient outcomes after living-donor kidney transplantation are similar in the short-term and medium-term for donors aged 55 to 65 years and for younger donors. Therefore, the use of OLD kidneys should be encouraged in China.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26308304     DOI: 10.1097/TP.0000000000000580

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.

Authors:  Daniel Gero; Fadia Dib; Maurice Matter; Manuel Pascual; Jean-Pierre Venetz; Nicolas Demartines; Emmanuel Melloul
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Comparison of accepted and unaccepted living kidney donors: one-center experience.

Authors:  Aleksandra Kezić; Svetlana Kovačević; Jelena Marinković; Stojanka Ristić; Dragana Radivojević; Radmila Blagojević-Lazić; Ljubica Djukanovic; Visnja D Ležaić
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

3.  Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review.

Authors:  Massimiliano Creta; Armando Calogero; Caterina Sagnelli; Gaia Peluso; Paola Incollingo; Maria Candida; Gianluca Minieri; Nicola Longo; Ferdinando Fusco; Vincenzo Tammaro; Concetta Anna Dodaro; Francesco Mangiapia; Nicola Carlomagno
Journal:  Biomed Res Int       Date:  2019-04-22       Impact factor: 3.411

4.  Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score-Matched Analysis.

Authors:  Saifu Yin; Turun Song; Yamei Jiang; Xingxing Li; Yu Fan; Tao Lin
Journal:  Ther Drug Monit       Date:  2019-06       Impact factor: 3.681

5.  Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation.

Authors:  Turun Song; Saifu Yin; Yamei Jiang; Zhongli Huang; Jinpeng Liu; Zhiling Wang; Linde Li; Jun Zeng; Yu Fan; Xianding Wang; Xingxing Li; Tao Lin
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.